Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors

Stuart Creedican; Claire M. Robinson; Katarzyna Mnich; Md Nahidul Islam; Eva Szegezdi; Ruth Clifford; Janusz Krawczyk; John B. Patterson; Stephen P. FitzGerald; Mark Summers; Ciaran Richardson; Kenneth Martin; Adrienne M. Gorman; Afshin Samali

doi:10.1111/jcmm.17479

Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors

Stuart Creedican
, Claire M. Robinson
, Katarzyna Mnich
, Md Nahidul Islam
, Eva Szegezdi
, Ruth Clifford
, Janusz Krawczyk
, John B. Patterson
, Stephen P. FitzGerald
, Mark Summers
, Ciaran Richardson
, Kenneth Martin
, Adrienne M. Gorman
, Afshin Samali

Cellular & Molecular Medicine

University of Galway
Randox Teoranta
University of Limerick School of Medicine
Limerick Regional General Hospital
Galway University Hospital
Orinove Inc.
Randox Laboratories Ltd.

Research output: Contribution to a Journal (Peer & Non Peer) › Letter › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	4629-4633
Number of pages	5
Journal	Journal of Cellular and Molecular Medicine
Volume	26
Issue number	16
DOIs	https://doi.org/10.1111/jcmm.17479
Publication status	Published - Aug 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1111/jcmm.17479

Cite this

Creedican, S., Robinson, C. M., Mnich, K., Islam, M. N., Szegezdi, E., Clifford, R., Krawczyk, J., Patterson, J. B., FitzGerald, S. P., Summers, M., Richardson, C., Martin, K., Gorman, A. M., & Samali, A. (2022). Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors. Journal of Cellular and Molecular Medicine, 26(16), 4629-4633. https://doi.org/10.1111/jcmm.17479

@article{69cc97b0bc914fc2952eeb326938e308,

title = "Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors",

author = "Stuart Creedican and Robinson, \{Claire M.\} and Katarzyna Mnich and Islam, \{Md Nahidul\} and Eva Szegezdi and Ruth Clifford and Janusz Krawczyk and Patterson, \{John B.\} and FitzGerald, \{Stephen P.\} and Mark Summers and Ciaran Richardson and Kenneth Martin and Gorman, \{Adrienne M.\} and Afshin Samali",

year = "2022",

month = aug,

doi = "10.1111/jcmm.17479",

language = "English",

volume = "26",

pages = "4629--4633",

journal = "Journal of Cellular and Molecular Medicine",

issn = "1582-1838",

publisher = "John Wiley and Sons Inc",

number = "16",

}

Creedican, S, Robinson, CM, Mnich, K, Islam, MN, Szegezdi, E, Clifford, R, Krawczyk, J, Patterson, JB, FitzGerald, SP, Summers, M, Richardson, C, Martin, K, Gorman, AM & Samali, A 2022, 'Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors', Journal of Cellular and Molecular Medicine, vol. 26, no. 16, pp. 4629-4633. https://doi.org/10.1111/jcmm.17479

TY - JOUR

T1 - Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors

AU - Creedican, Stuart

AU - Robinson, Claire M.

AU - Mnich, Katarzyna

AU - Islam, Md Nahidul

AU - Szegezdi, Eva

AU - Clifford, Ruth

AU - Krawczyk, Janusz

AU - Patterson, John B.

AU - FitzGerald, Stephen P.

AU - Summers, Mark

AU - Richardson, Ciaran

AU - Martin, Kenneth

AU - Gorman, Adrienne M.

AU - Samali, Afshin

PY - 2022/8

Y1 - 2022/8

UR - https://www.scopus.com/pages/publications/85134035831

U2 - 10.1111/jcmm.17479

DO - 10.1111/jcmm.17479

M3 - Letter

C2 - 35822520

AN - SCOPUS:85134035831

SN - 1582-1838

VL - 26

SP - 4629

EP - 4633

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

IS - 16

ER -

Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors

UN SDGs

Access to Document

Other files and links

Cite this